REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,000 | -97.5% | 16,548 | -92.4% | 0.00% | -97.2% |
| Q4 2021 | $563,000 | +17.3% | 218,338 | +108.4% | 0.07% | +44.9% |
| Q3 2021 | $480,000 | -14.7% | 104,754 | +28.1% | 0.05% | -22.2% |
| Q2 2021 | $563,000 | +323.3% | 81,778 | +350.5% | 0.06% | +186.4% |
| Q1 2021 | $133,000 | -63.1% | 18,151 | -59.3% | 0.02% | -62.7% |
| Q4 2020 | $360,000 | – | 44,568 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |